Topic resource collection
Approved comparison material connected to this topic.
774 resourcesRead both sides
BPC-157 VEGF upregulation, angiogenesis, fibroblast migration to ulcer site 250–500mcg SC twice daily (investigational human); 10–100mcg/kg in animal studies 48–72 hours for measurable vascular changes; 7–14 days for gross mucosa…
Survodutide (GLP-1/Glucagon) Incretin receptor agonism + hepatic fat oxidation High. Glucagon receptors densely expressed in visceral adipocytes 15.7% body weight reduction, 18.2% visceral fat reduction (Phase 2, The Lancet) ~5 d…
BPC-157 VEGF upregulation, FAK-paxillin pathway activation → axonal outgrowth Rat sciatic nerve transection model: 40% faster motor recovery vs saline (2020, Eur J Pharmacol) 250–500mcg SubQ daily No Phase 2+ human trials in neur…
The table below compares mechanisms, clinical evidence, dosing protocols, and administration for the peptides most studied in menopause-related metabolic dysfunction. CJC-1295 + Ipamorelin GHRH analog + ghrelin mimetic; stimulate…
| Peptide | Primary Mechanism | Thyroid Function Impact | Metabolic Rate Effect | Insulin Sensitivity | Evidence Quality | Professional Assessment ||—|—|—|—|—|—|| Thymalin | TSH pulse modulation, thyroid follicle protection | Dir…
Research-grade peptides used in clinical trials differ from consumer products in three critical ways: purity, concentration, and vehicle formulation. Laboratory-grade peptides are synthesised to 98–99% purity with verified amino-…
Beta-defensins (hBD-1, hBD-2, hBD-3) Yes. MIC 2–8 μg/mL against C. albicans Membrane disruption via pore formation Multiple in vitro studies; limited human trials Strongest documented anti-Candida activity but not orally bioavail…
BPC-157 VEGF upregulation, angiogenesis, FAK-paxillin pathway activation Case reports and observational data only. No RCTs in diabetic neuropathy Subcutaneous or intramuscular injection 250–500 mcg daily in research models Strong…
GHK-Cu (Copper Peptide) Activates lysyl oxidase to cross-link collagen; downregulates IL-6 and TNF-α inflammatory cytokines Topical (penetrates at 340 Daltons) or microneedling Atrophic scars, mature scars needing remodeling High…
KPV (Lysine-Proline-Valine) NF-κB inhibition; reduces pro-inflammatory cytokine transcription (TNF-α, IL-6, IL-8) Mast cell activation and neutrophil chemotaxis Inflammation Research 2019: 52% reduction in IL-6 secretion at 10μM …
Kojic Acid Dipeptide Tyrosinase inhibition via copper chelation 2–3% active peptide 34–47% melanin reduction over 12 weeks (Stanford study, 2023) Most direct tyrosinase inhibitor with proven clinical results. Requires stable form…
GHK-Cu (Copper Peptide) TGF-β1 suppression, lysyl oxidase activation, organized collagen synthesis Microneedling + topical serum (2–5% concentration), or iontophoresis 2–5% topical serum applied 2× daily, or 0.1–0.5 mA iontophore…
The gap between animal models and human clinical trials is where most peptide therapies stall. BPC-157 has robust preclinical data across nerve crush injuries, diabetic neuropathy models, and chemotherapy-induced peripheral neuro…
| Peptide | Mechanism | VAT Reduction Evidence | Half-Life | Administration | Appetite Impact | Professional Assessment ||—|—|—|—|—|—|| CJC-1295/Ipamorelin | GHRH analog + ghrelin agonist. Dual GH elevation | 12.4% VAT reduction …
The following table compares the best peptides for chronic inflammation by mechanism, evidence base, and typical research dosing protocols used in published studies. BPC-157 VEGFR2 agonism, angiogenesis promotion, NF-κB modulatio…
The table below compares the most effective peptide protocols for body recomposition based on mechanism, dosing logistics, and expected outcomes over a 12-week cycle. CJC-1295/Ipamorelin GHRH/GHRP synergy. Pulsatile GH/IGF-1 elev…
Different peptides address distinct underlying mechanisms. Choosing the right compound depends on whether the libido deficit stems from central arousal pathways, hormonal axis suppression, or emotional/pair-bonding impairment. Th…
Selecting the appropriate peptide for cognitive decline research requires matching mechanism to research question. The table below compares primary mechanisms, administration routes, and key research applications for leading cogn…
The following comparison table evaluates the primary research peptides investigated for tendon and connective tissue repair based on mechanism of action, documented preclinical effects, typical research protocols, and key conside…
The table below compares the primary sleep-modulating peptides by mechanism, dosing framework, cycle structure, and target sleep pathology. Each peptide addresses a distinct biological pathway driving insomnia. Selection depends …